Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2030 ARTíCULOS , VIENDO DEL 31 AL 45

PUBMED

Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease.

Simunovic F, Yi M, Wang Y, Stephens R, Sonntag KC.

PLoS One. 2010 Jan 25;5(1):e8856. doi: 10.1371/journal.pone.0008856.

0

0

0

PUBMED

WHOQOL-OLD assessment of quality of life in elderly patients with Parkinson's disease: influence of sleep and depressive symptoms.

Margis R, Donis KC, Schönwald SV, Rieder CR.

Rev Bras Psiquiatr. 2010 Jun;32(2):125-31.

0

0

0

PUBMED

Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.

Adamiak U, Kaldonska M, Klodowska-Duda G, Wyska E, Safranow K, Bialecka M, Gawronska-Szklarz B.

Clin Neuropharmacol. 2010 May;33(3):135-41. doi: 10.1097/WNF.0b013e3181d47849.

0

0

0

PUBMED

[Gene for sporadic Parkinson's disease: common disease-common variants].

Toda T, Satake W.

Rinsho Shinkeigaku. 2010 Nov;50(11):864. Japanese. No abstract available.

0

0

0

PUBMED

Parkinson disease: Deep brain stimulation can alter speech-related respiratory and laryngeal control in Parkinson disease.

Wood H.

Nat Rev Neurol. 2010 Sep;6(9):468. doi: 10.1038/nrneurol.2010.121. No abstract available.

0

0

0

PUBMED

Design, synthesis and biological evaluation of L-dopa amide derivatives as potential prodrugs for the treatment of Parkinson's disease.

Zhou T, Hider RC, Jenner P, Campbell B, Hobbs CJ, Rose S, Jairaj M, Tayarani-Binazir KA, Syme A.

Eur J Med Chem. 2010 Sep;45(9):4035-42. doi: 10.1016/j.ejmech.2010.05.062.

0

0

0

PUBMED

Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease.

Kalivendi SV, Yedlapudi D, Hillard CJ, Kalyanaraman B.

Free Radic Biol Med. 2010 Feb 1;48(3):377-83. doi: 10.1016/j.freeradbiomed.2009.10.045.

0

0

0

PUBMED

Arm swing magnitude and asymmetry during gait in the early stages of Parkinson's disease.

Lewek MD, Poole R, Johnson J, Halawa O, Huang X.

Gait Posture. 2010 Feb;31(2):256-60. doi: 10.1016/j.gaitpost.2009.10.013.

0

0

0

PUBMED

Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease.

Spiegel J.

Parkinsons Dis. 2010;2010:295346. doi: 10.4061/2010/295346.

0

0

0

PUBMED

Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia.

Darreh-Shori T, Jelic V.

Expert Opin Drug Saf. 2010 Jan;9(1):167-76. doi: 10.1517/14740330903439717. Review.

0

0

0

PUBMED

Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease.

Mace JL, Porter RJ, Dalrymple-Alford JC, Wesnes KA, Anderson TJ.

J Psychopharmacol. 2010 Oct;24(10):1465-72. doi: 10.1177/0269881109105721.

0

0

0

PUBMED

INPH and Parkinson disease: differentiation by levodopa response.

Morishita T, Foote KD, Okun MS.

Nat Rev Neurol. 2010 Jan;6(1):52-6. doi: 10.1038/nrneurol.2009.195.

0

0

0

PUBMED

Substantia nigra hyperechogenicity in Parkinson's disease.

Bor-Seng-Shu E, Fonoff ET, Barbosa ER, Teixeira MJ.

Acta Neurochir (Wien). 2010 Dec;152(12):2085-7. doi: 10.1007/s00701-010-0736-0. Review. No abstract available.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy